After treatment, cells were harvested, washed once with PBS, and lysed using 6 M urea buffer supplemented with a cocktail of protease and phosphatase inhibitors, namely aprotinin, leupeptin, pepstatin, PMSF, sodium orthovanadate, and sodium pyrophosphate. Protein content of samples was determined using
Bradford reagent (Sigma-Aldrich). SDS-PAGE was subsequently performed to resolve the samples, and proteins were then transferred onto
PVDF membranes (GE Healthcare, Munich, Germany). Membranes were washed once in TBS-Tween for 5 min, and then blocked for 1 h at room temperature using 5% non-fat dry milk in TBS/Tween. Membranes were then washed once in TBS/Tween for 5 min and were incubated overnight at 4 °C with the primary antibody. Anti-VDUP1 (TXNIP) antibody was purchased from MBL, whereas anti-β-actin and anti-vinculin antibodies were purchased from Santa Cruz Biotechnology. Anti-ITCH, anti-phospho-ACC
(S79), as well as
anti-mouse and rabbit IgG horseradish peroxidase (HRP)-linked antibodies were purchased from Cell signaling technologies. Western Lightning
TM Plus-ECl (Perkin Elmer) was utilized as HRP substrate. Target proteins were detected using the Fujifilm
LAS-3000 imaging system.
Abu el Maaty M.A., Almouhanna F, & Wölfl S. (2018). Expression of TXNIP in Cancer Cells and Regulation by 1,25(OH)2D3: Is It Really the Vitamin D3 Upregulated Protein?. International Journal of Molecular Sciences, 19(3), 796.